A detailed history of Ubs Group Ag transactions in Icon PLC stock. As of the latest transaction made, Ubs Group Ag holds 59,119 shares of ICLR stock, worth $12.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,119
Previous 59,499 0.64%
Holding current value
$12.6 Million
Previous $18.7 Million 8.9%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$280.48 - $346.2 $106,582 - $131,556
-380 Reduced 0.64%
59,119 $17 Million
Q2 2024

Aug 13, 2024

BUY
$288.23 - $331.73 $1.94 Million - $2.23 Million
6,731 Added 12.76%
59,499 $18.7 Million
Q1 2024

May 13, 2024

BUY
$247.84 - $340.0 $2.76 Million - $3.79 Million
11,135 Added 26.75%
52,768 $17.7 Million
Q4 2023

Feb 09, 2024

BUY
$222.83 - $285.76 $4.65 Million - $5.96 Million
20,850 Added 100.32%
41,633 $11.8 Million
Q3 2023

Nov 09, 2023

BUY
$236.44 - $265.62 $300,042 - $337,071
1,269 Added 6.5%
20,783 $5.12 Million
Q2 2023

Aug 11, 2023

BUY
$183.12 - $250.2 $9,888 - $13,510
54 Added 0.28%
19,514 $4.88 Million
Q1 2023

May 12, 2023

SELL
$193.59 - $245.33 $65,627 - $83,166
-339 Reduced 1.71%
19,460 $4.16 Million
Q4 2022

Feb 08, 2023

BUY
$173.9 - $224.8 $135,815 - $175,568
781 Added 4.11%
19,799 $3.85 Million
Q3 2022

Nov 10, 2022

BUY
$183.25 - $247.5 $198,276 - $267,795
1,082 Added 6.03%
19,018 $3.49 Million
Q2 2022

Aug 10, 2022

SELL
$197.3 - $261.32 $2.42 Million - $3.21 Million
-12,266 Reduced 40.61%
17,936 $3.89 Million
Q1 2022

May 16, 2022

BUY
$216.09 - $296.03 $156,881 - $214,917
726 Added 2.46%
30,202 $7.35 Million
Q4 2021

Feb 14, 2022

BUY
$258.11 - $309.7 $2.39 Million - $2.87 Million
9,269 Added 45.87%
29,476 $9.13 Million
Q3 2021

Nov 15, 2021

SELL
$208.53 - $283.04 $807,428 - $1.1 Million
-3,872 Reduced 16.08%
20,207 $5.3 Million
Q2 2021

Aug 13, 2021

BUY
$194.07 - $232.2 $1.5 Million - $1.79 Million
7,710 Added 47.1%
24,079 $4.98 Million
Q1 2021

May 12, 2021

SELL
$171.87 - $220.96 $1.84 Million - $2.36 Million
-10,680 Reduced 39.48%
16,369 $3.21 Million
Q4 2020

Feb 11, 2021

SELL
$180.3 - $214.08 $628,706 - $746,496
-3,487 Reduced 11.42%
27,049 $5.27 Million
Q3 2020

Nov 12, 2020

SELL
$166.91 - $196.1 $1.13 Million - $1.32 Million
-6,749 Reduced 18.1%
30,536 $5.84 Million
Q2 2020

Jul 31, 2020

SELL
$129.79 - $170.94 $1.24 Million - $1.64 Million
-9,568 Reduced 20.42%
37,285 $6.28 Million
Q1 2020

May 01, 2020

BUY
$115.95 - $177.22 $2.74 Million - $4.18 Million
23,608 Added 101.56%
46,853 $6.37 Million
Q4 2019

Feb 14, 2020

SELL
$139.48 - $172.23 $426,111 - $526,162
-3,055 Reduced 11.62%
23,245 $4 Million
Q3 2019

Nov 14, 2019

SELL
$146.89 - $161.41 $310,231 - $340,897
-2,112 Reduced 7.43%
26,300 $3.88 Million
Q2 2019

Aug 14, 2019

SELL
$129.99 - $153.97 $461,984 - $547,209
-3,554 Reduced 11.12%
28,412 $4.38 Million
Q1 2019

May 14, 2019

SELL
$121.3 - $146.95 $1.21 Million - $1.47 Million
-10,010 Reduced 23.85%
31,966 $4.37 Million
Q4 2018

Feb 14, 2019

SELL
$119.37 - $153.29 $862,686 - $1.11 Million
-7,227 Reduced 14.69%
41,976 $5.42 Million
Q3 2018

Nov 14, 2018

BUY
$131.3 - $153.75 $566,165 - $662,970
4,312 Added 9.61%
49,203 $7.57 Million
Q2 2018

Aug 14, 2018

SELL
$111.38 - $137.03 $2.24 Million - $2.76 Million
-20,111 Reduced 30.94%
44,891 $5.95 Million
Q1 2018

May 15, 2018

SELL
$103.82 - $123.9 $1.54 Million - $1.83 Million
-14,795 Reduced 18.54%
65,002 $7.68 Million
Q4 2017

Feb 14, 2018

BUY
$111.14 - $123.05 $1.48 Million - $1.64 Million
13,294 Added 19.99%
79,797 $8.95 Million
Q3 2017

Nov 14, 2017

SELL
$101.4 - $116.62 $2.59 Million - $2.98 Million
-25,524 Reduced 27.74%
66,503 $7.57 Million
Q2 2017

Aug 14, 2017

BUY
N/A
4,826 Added 5.53%
92,027 $9 Million
Q1 2017

Nov 14, 2017

BUY
N/A
87,201
87,201 $6.95 Million

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $17.4B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.